Viewing StudyNCT00050596

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00050596
Status: COMPLETED
Last Update Posted: 2011-06-27
First Post: 2002-12-16
Brief Title: Comparison Study of MDX-010 CTLA-4 Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords: